Azacitidine
USP/1045520 - United States Pharmacopeia (USP) Reference Standard
Synonym: 5-Azacytidine; 4-Amino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one; Ladakamycin
CAS Number: 320-67-2
Empirical Formula (Hill Notation): C8H12N4O5
Molecular Weight: 244.20
MDL Number: MFCD00006539
Linear Formula: C8H12N4O5
Product Type: Chemical
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C8H12N4O5/c9-7-10-2-12 |
InChI key | NMUSYJAQQFHJEW-KVTDHHQDSA |
manufacturer/tradename | USP |
mp | 226-232 °C (dec.) (lit.) |
SMILES string | NC1=NC(=O)N(C=N1)[C@@H]2O |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Biochem/physiol Actions: | A potent growth inhibitor and cytotoxic agent; inhibits DNA methyltransferase, an important regulatory mechanism of gene expression, gene activation and silencing. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Other Notes: | USP issued SDS can be found here . |
Symbol | GHS07,GHS08 |
Signal word | Danger |
Hazard statements | H302 - H360D |
Precautionary statements | P201 - P301 + P312 + P330 - P308 + P313 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
mp | 226-232 °C (dec.) (lit.) |
UNSPSC | 41116107 |